| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/13/2006 | US7059199 Multiphase Coriolis flowmeter |
| 06/13/2006 | US7059180 Water cut rate of change analytic method |
| 06/13/2006 | US7059176 Resonant tube viscosity sensing device |
| 06/13/2006 | US7059174 Method and probe for measuring hydraulic conductivity of soil |
| 06/13/2006 | US7059172 Phase flow measurement in pipes using a density meter |
| 06/13/2006 | US7059169 Fluid aeration test apparatus and method |
| 06/13/2006 | US7059139 System for preparing cutaneous tissue samples for oncological histology study and diagnosis |
| 06/13/2006 | CA2427818C Apparatus and method for testing stiffness of articles |
| 06/13/2006 | CA2407760C Methods for diagnosis of low grade astrocytoma |
| 06/13/2006 | CA2341021C Method for determining warp potential in wood |
| 06/13/2006 | CA2182793C Automated cytological specimen classification system and method |
| 06/13/2006 | CA1341508C Transforming growth factor peptides |
| 06/08/2006 | WO2006060799A2 Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis |
| 06/08/2006 | WO2006060793A2 Diagnosis of conditions associated with decreased arginine bioavailability |
| 06/08/2006 | WO2006060753A2 Diagnosis and treatment of alzheimer's disease |
| 06/08/2006 | WO2006060743A2 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 06/08/2006 | WO2006060739A2 Ubiquitin ligase assays and related reagents |
| 06/08/2006 | WO2006060709A2 Biological pathways in progenitor cells |
| 06/08/2006 | WO2006060643A2 Novel bladder matrix protein peptides and methods of detection of bladder cancer |
| 06/08/2006 | WO2006060591A2 Determination of cell viability and phenotype |
| 06/08/2006 | WO2006060484A2 Tuberculosis nucleic acids, polypeptides and immunogenic compositions |
| 06/08/2006 | WO2006060419A2 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 06/08/2006 | WO2006060386A1 Method for diagnosing critically ill patients |
| 06/08/2006 | WO2006060347A1 Portable and on-line x-ray analyzer |
| 06/08/2006 | WO2006060291A2 Apparatus and method for transferring data to a pharmaceutical compounding system |
| 06/08/2006 | WO2006060188A2 Anti-tenascin monoclonal antibody immunoassays and diagnostic kits |
| 06/08/2006 | WO2006060172A2 Methods for identifying graft rejection suppressing compounds |
| 06/08/2006 | WO2006060063A2 Method for determination of organic hydroperoxides |
| 06/08/2006 | WO2006060041A1 Coated water soluble nanoparticles |
| 06/08/2006 | WO2006060016A1 Relative humidity probe for concrete |
| 06/08/2006 | WO2006059911A1 Method of sample analysis and apparatus therefor |
| 06/08/2006 | WO2006059807A1 Screening method for ribosome recycling inhibitor |
| 06/08/2006 | WO2006059769A1 Method of diagnosing malignant lymphoma and estimating the prognosis thereof |
| 06/08/2006 | WO2006059727A1 Detection and analysis system for protein array |
| 06/08/2006 | WO2006059712A1 Monoclonal antibody binding to human steroid sulfatase |
| 06/08/2006 | WO2006059691A1 Method of screening antiobesity drug |
| 06/08/2006 | WO2006059664A1 Stabilized inorganic nanoparticle, stabilized inorganic nanoparticles, process for producing stabilized inorganic nanoparticle, and method of utilizing stabilized inorganic nanoparticle |
| 06/08/2006 | WO2006059637A1 Agent for diagnosing, preventing and treating adhesion with the use of ccr8 inhibitor |
| 06/08/2006 | WO2006059423A1 Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method |
| 06/08/2006 | WO2006059408A1 Lactic acid bacterium binding to human abo blood types |
| 06/08/2006 | WO2006059327A1 A biological marker for inflammation |
| 06/08/2006 | WO2006059258A2 Excitation and measurement method for a magnetic biosensor |
| 06/08/2006 | WO2006059232A1 Cassette assembly drive means and method |
| 06/08/2006 | WO2006059138A2 Measurement of soil pollution |
| 06/08/2006 | WO2006059132A1 Method of optimizing parameters in the entire process of analysing a dna containing sample and method of modeling said process |
| 06/08/2006 | WO2006059125A2 Tumour suppressor genes |
| 06/08/2006 | WO2006059121A2 Modulators of spindle checkpoint kinases and a taxol |
| 06/08/2006 | WO2006059111A2 Fungal signalling and metabolic enzymes |
| 06/08/2006 | WO2006059001A1 Device for measuring in situ metal ion content of water |
| 06/08/2006 | WO2006058936A1 Method of detecting antibiotic residues and other antimicrobial compounds |
| 06/08/2006 | WO2006058919A1 Method for concentrating biomolecules |
| 06/08/2006 | WO2006058900A1 The lupac bifunctional marker and its use in protein production |
| 06/08/2006 | WO2006058889A1 G protein coupled receptor |
| 06/08/2006 | WO2006058878A1 Aging biomarker |
| 06/08/2006 | WO2006058877A1 A differential gas component probe having a passage containing a reaction catalyst |
| 06/08/2006 | WO2006058778A2 Luminescent indicator dye and optical sensor |
| 06/08/2006 | WO2006058653A2 Diagnostic system for determining substance concentrations in liquid samples |
| 06/08/2006 | WO2006058645A1 Particle based binding assay |
| 06/08/2006 | WO2006058610A1 Lateral-flow test device providing improved test result validity |
| 06/08/2006 | WO2006058431A1 Laminin receptor binding molecule |
| 06/08/2006 | WO2006058406A1 Systems and methods for defect sorting of produce |
| 06/08/2006 | WO2006058385A1 Multiplex-bead complex for determination of lysosomal storage disorders |
| 06/08/2006 | WO2006058375A1 Identification of compounds for the treatment of proliferative disorders |
| 06/08/2006 | WO2006044066A3 Apparatus and process for monitoring migratory cell proliferation |
| 06/08/2006 | WO2006042111A3 Raman-active particles and methods of making and using them |
| 06/08/2006 | WO2006037657A3 Quadruple transformed cell line useful for the identification of transport inhibitors |
| 06/08/2006 | WO2006037573B1 Type pept1 protein assay |
| 06/08/2006 | WO2006037570A3 Protein assay of type sglt1 |
| 06/08/2006 | WO2006024875A3 Method for determinig protein solubility |
| 06/08/2006 | WO2006023504A3 Method and apparatus for magnetic sensing and control of reagents |
| 06/08/2006 | WO2006020302A3 Biomarkers for bladder cancer |
| 06/08/2006 | WO2006013474A3 PPGALNAC-t6 MRNA or peptide as a new marker for detection cancer cells |
| 06/08/2006 | WO2006010517A3 Diagnostics and therapeutics for diseases associated with fibroblast activation protein (fap) |
| 06/08/2006 | WO2006010495A3 Diagnostics and therapeutics for diseases associated with carboxypeptidase a3 (cpa3) |
| 06/08/2006 | WO2006008009A3 Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6) |
| 06/08/2006 | WO2006007472A3 Non-invasive glucose measurement |
| 06/08/2006 | WO2006005459A3 Diagnostics and therapeutics for diseases associated with thyrotropin-releasing hormone degrading ectoenzyme (trhde) |
| 06/08/2006 | WO2006004620A3 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/08/2006 | WO2006000464A3 Method for discovering pain-relevant substances using pain-relevant proteins |
| 06/08/2006 | WO2005116632A3 Analytical systems, devices, and cartridges therefor |
| 06/08/2006 | WO2005114107A8 Use of a monoclonal antibody that specifically binds stem cells |
| 06/08/2006 | WO2005112985A3 Means and method for diagnosis prophylaxis and therapy of connective tissue diseases |
| 06/08/2006 | WO2005098039A3 Method and apparatus for analyzing and generating human antibody amino acid and nucleic acid sequences |
| 06/08/2006 | WO2005097818A3 An assay system for screening protease inhibitors |
| 06/08/2006 | WO2005092926A3 Reducing the risk of human and anti-human antibodies through v gene manipulation |
| 06/08/2006 | WO2005089043A3 Prostate stem cell |
| 06/08/2006 | WO2005085423A8 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors |
| 06/08/2006 | WO2005084194A3 Methods of evaluating efficacy of an immune response by assessing alpha-1 integrin expression |
| 06/08/2006 | WO2005076938A3 Multi-polymer-coated magnetic nanoclusters |
| 06/08/2006 | WO2005076893A3 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 06/08/2006 | WO2005069900A3 Npc1l1 (npc3) and methods of identifying ligands thereof |
| 06/08/2006 | WO2005050210A3 Methods, systems and devices for performing analytical protocols |
| 06/08/2006 | WO2005042795A3 Plasma polymerization of atomically modified surfaces |
| 06/08/2006 | WO2005038429A3 Method and apparatus for analysis of molecular configurations and combinations |
| 06/08/2006 | WO2005023191A3 Rage-related methods and compositions for treating glomerular injury |
| 06/08/2006 | WO2005008215A3 Methods and apparatus for characterising cells and treatments |
| 06/08/2006 | WO2005002527A3 Sirt1 modulation of adipogenesis and adipose function |
| 06/08/2006 | WO2004087866A3 Methods for the identification of inhibitors of lipid transfer protein activity in plants |
| 06/08/2006 | WO2004073653A3 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 06/08/2006 | WO2003089904A3 Aib1 as a prognostic marker and predictor of resistance to encocrine therapy |